Literature DB >> 24658432

Impaired CTLA-4 responses in COPD are associated with systemic inflammation.

Dino B A Tan1, Sonia Fernandez2, Patricia Price2, Martyn A French3, Philip J Thompson4, Yuben P Moodley5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24658432      PMCID： PMC4220831          DOI： 10.1038/cmi.2014.20

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  10 in total

Review 1.  Global burden of COPD: risk factors, prevalence, and future trends.

Authors:  David M Mannino; A Sonia Buist
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

Review 2.  Immunologic aspects of chronic obstructive pulmonary disease.

Authors:  Manuel G Cosio; Marina Saetta; Alvar Agusti
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

3.  Influence of smoking cessation on airway T lymphocyte subsets in COPD.

Authors:  Ester Roos-Engstrand; Barbro Ekstrand-Hammarström; Jamshid Pourazar; Annelie F Behndig; Anders Bucht; Anders Blomberg
Journal:  COPD       Date:  2009-04       Impact factor: 2.409

4.  The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients.

Authors:  Shuyuan Chu; Xiaoning Zhong; Jianquan Zhang; Qifang Lao; Zhiyi He; Jing Bai
Journal:  Int Immunopharmacol       Date:  2011-07-23       Impact factor: 4.932

5.  Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.

Authors:  Juanita H Vernooy; Mehmet Küçükaycan; Jan A Jacobs; Niels H Chavannes; Wim A Buurman; Mieke A Dentener; Emiel F Wouters
Journal:  Am J Respir Crit Care Med       Date:  2002-11-01       Impact factor: 21.405

Review 6.  Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence.

Authors:  Nicola J Sinden; Robert A Stockley
Journal:  Thorax       Date:  2010-07-13       Impact factor: 9.139

7.  CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease.

Authors:  Yun Liu; Wei-Bo Liang; Lin-Bo Gao; Xin-Min Pan; Tian-Yi Chen; Yan-Yun Wang; Hui Xue; Lu-shun Zhang; Lin Zhang
Journal:  Hum Immunol       Date:  2010-08-21       Impact factor: 2.850

8.  T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients.

Authors:  A Di Stefano; G Caramori; I Gnemmi; M Contoli; C Vicari; A Capelli; F Magno; S E D'Anna; A Zanini; P Brun; P Casolari; K F Chung; P J Barnes; A Papi; I Adcock; B Balbi
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

9.  CTLA4 gene polymorphisms are associated with chronic bronchitis.

Authors:  G Zhu; A Agusti; A Gulsvik; P Bakke; H Coxson; D A Lomas; E K Silverman; S G Pillai
Journal:  Eur Respir J       Date:  2009-04-22       Impact factor: 16.671

10.  CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.

Authors:  Erika von Euw; Thinle Chodon; Narsis Attar; Jason Jalil; Richard C Koya; Begonya Comin-Anduix; Antoni Ribas
Journal:  J Transl Med       Date:  2009-05-20       Impact factor: 5.531
  10 in total
  5 in total

1.  Levels of CMV-reactive antibodies correlate with the induction of CD28(null) T cells and systemic inflammation in chronic obstructive pulmonary disease (COPD).

Authors:  Dino B A Tan; Fathiah S Amran; Teck-Hui Teo; Patricia Price; Yuben P Moodley
Journal:  Cell Mol Immunol       Date:  2015-01-26       Impact factor: 11.530

2.  Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection.

Authors:  Chen Xi Yang; Michael Tomchaney; Manuel F Landecho; Borja R Zamacona; Marta Marin Oto; Javier Zulueta; Joshua Malo; Steve Knoper; Marco Contoli; Alberto Papi; Dragoş M Vasilescu; Maor Sauler; Christof Straub; Cheryl Tan; Fernando D Martinez; Deepta Bhattacharya; Ivan O Rosas; Farrah Kheradmand; Tillie-Louise Hackett; Francesca Polverino
Journal:  Cells       Date:  2022-06-07       Impact factor: 7.666

Review 3.  Association of SARS-CoV-2 and Polypharmacy with Gut-Lung Axis: From Pathogenesis to Treatment.

Authors:  Jonaid Ahmad Malik; Sakeel Ahmed; Zahid Yaseen; Muteb Alanazi; Tareq Nafea Alharby; Hisham Abdulaziz Alshammari; Sirajudheen Anwar
Journal:  ACS Omega       Date:  2022-09-16

4.  Fibrinogen is a promising biomarker for chronic obstructive pulmonary disease: evidence from a meta-analysis.

Authors:  Bo Zhou; Shufang Liu; Danni He; Kundi Wang; Yunfeng Wang; Ting Yang; Qi Zhang; Zhixin Zhang; Wenquan Niu
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

Review 5.  Role of microbiota on lung homeostasis and diseases.

Authors:  Jian Wang; Fengqi Li; Zhigang Tian
Journal:  Sci China Life Sci       Date:  2017-10-09       Impact factor: 6.038
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.